Clinical Trial Update: Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated intravenous and oral esomeprazole to prevent recurrent bleeding after endoscopic therapy for peptic ulcers. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcer Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)

Snippet

Sponsor: Chinese University of Hong Kong | Conditions: Peptic Ulcer, Bleeding | Phase 3 | Status: COMPLETED